Ownership
Private
Employees
~200
Therapeutic Areas
Women's HealthDermatologyRheumatology
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Autologous fat grafting (adipose-derived)Platelet-rich plasma (PRP)Acellular dermal matrix (ADM)Microfat transferStem cell-based therapies

Bimini Health Tech General Information

Bimini Health Tech has commercialized a suite of FDA-cleared medical devices used globally in over a million procedures. Its flagship products include PureGraft® systems for fat grafting, Essence ADM™ for reconstructive surgery, Serene™ saline breast implants, and Healeon PRP®. The company’s Kerastem hair therapy showed statistically significant results in Phase II trials but is not yet available in the US. In November 2024, Bimini received new FDA clearance for its next-generation Float PRP system.

Contact Information

Primary Industry
Implantable Medical Devices
Corporate Office
Plano, Texas
United States

Drug Pipeline

No pipeline data available

For full access to Bimini Health Tech's pipeline data

Book a demo

Key Partnerships

Strategic partnerships referenced but not named specifically; collaborations with top physicians/surgeons are highlighted.

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Bimini Health Tech Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Bimini Health Tech's complete valuation and funding history, request access »

Bimini Health Tech Financial Metrics